| Dr David S Sandock, MD | |
|
2311 N Prospect Ave, Milwaukee, WI 53211-4445 | |
| (414) 319-3000 | |
| Not Available |
| Full Name | Dr David S Sandock |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 34 Years |
| Location | 2311 N Prospect Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124015961 | NPI | - | NPPES |
| 32233400 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 37739 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Ascension St Francis Hospital | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbia St Marys Hospital Milwaukee Inc | 5890604722 | 279 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema secondary to Retinal Vein Occlusion (RVO).
A new study published in Nature Communications shows that infants who are later diagnosed with autism react more strongly to sudden changes in light.
Despite the well-documented benefits of walking after surgery, some patients are reluctant to make an attempt even with the encouragement of medical staff. Loyola University Health System researchers reported these findings at the prestigious 38th Annual Scientific Meeting of the Society of Gynecologic Surgeons in Baltimore.
An estimated 1.3 million people in the United States suffer from rheumatoid arthritis. The causes behind this chronic disease — which can exhibit itself as pain, swelling, stiffness, deformation, and loss of function in the joints — have eluded scientists for centuries. A new study by UNC researchers offers tantalizing glimmers about the roles of a gene called CCR2, an immune system cell called Th17 cell, and a missing monocyte.
Seattle-based biotech company Kineta, Inc. announced today it has received regulatory clearance in the Netherlands to initiate a first-in-human trial of ShK-186, an autoimmune drug candidate that specifically inhibits the Kv1.3 potassium ion channel.
› Verified 2 days ago
| Entity Name | Columbia St Marys Hospital Milwaukee Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023064482 PECOS PAC ID: 5890604722 Enrollment ID: O20031105000057 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema secondary to Retinal Vein Occlusion (RVO).
A new study published in Nature Communications shows that infants who are later diagnosed with autism react more strongly to sudden changes in light.
Despite the well-documented benefits of walking after surgery, some patients are reluctant to make an attempt even with the encouragement of medical staff. Loyola University Health System researchers reported these findings at the prestigious 38th Annual Scientific Meeting of the Society of Gynecologic Surgeons in Baltimore.
An estimated 1.3 million people in the United States suffer from rheumatoid arthritis. The causes behind this chronic disease — which can exhibit itself as pain, swelling, stiffness, deformation, and loss of function in the joints — have eluded scientists for centuries. A new study by UNC researchers offers tantalizing glimmers about the roles of a gene called CCR2, an immune system cell called Th17 cell, and a missing monocyte.
Seattle-based biotech company Kineta, Inc. announced today it has received regulatory clearance in the Netherlands to initiate a first-in-human trial of ShK-186, an autoimmune drug candidate that specifically inhibits the Kv1.3 potassium ion channel.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David S Sandock, MD 4425 N Port Washington Rd, Attn: Csmcp Clinic Credentialing, Glendale, WI 53212-1082 Ph: (414) 319-3000 | Dr David S Sandock, MD 2311 N Prospect Ave, Milwaukee, WI 53211-4445 Ph: (414) 319-3000 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema secondary to Retinal Vein Occlusion (RVO).
A new study published in Nature Communications shows that infants who are later diagnosed with autism react more strongly to sudden changes in light.
Despite the well-documented benefits of walking after surgery, some patients are reluctant to make an attempt even with the encouragement of medical staff. Loyola University Health System researchers reported these findings at the prestigious 38th Annual Scientific Meeting of the Society of Gynecologic Surgeons in Baltimore.
An estimated 1.3 million people in the United States suffer from rheumatoid arthritis. The causes behind this chronic disease — which can exhibit itself as pain, swelling, stiffness, deformation, and loss of function in the joints — have eluded scientists for centuries. A new study by UNC researchers offers tantalizing glimmers about the roles of a gene called CCR2, an immune system cell called Th17 cell, and a missing monocyte.
Seattle-based biotech company Kineta, Inc. announced today it has received regulatory clearance in the Netherlands to initiate a first-in-human trial of ShK-186, an autoimmune drug candidate that specifically inhibits the Kv1.3 potassium ion channel.
› Verified 2 days ago
Mark Ehlers, Urology Medicare: Medicare Enrolled Practice Location: 2801 W Kinnickinnic River Pkwy Ste 330, Milwaukee, WI 53215 Phone: 414-649-1280 Fax: 414-649-1288 | |
Dr. Michael L Guralnick, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Department Of Urology, Milwaukee, WI 53226 Phone: 414-805-0805 Fax: 414-805-0771 | |
Dr. Arman Cicic, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 2600 N Mayfair Rd Ste 580, Milwaukee, WI 53226 Phone: 414-476-0430 | |
Dr. Pedro M. Banda, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2311 N Prospect Ave, Milwaukee, WI 53211 Phone: 414-319-3000 Fax: 414-319-3087 | |
Dr. Jay I Sandlow, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Dept Of Urology, Milwaukee, WI 53226 Phone: 414-805-0805 Fax: 414-805-0771 | |
Joshua Alan Bodie, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Department Of Urology, Milwaukee, WI 53226 Phone: 414-805-0805 Fax: 414-805-0771 | |
Mr. Michael Ernst Mitchell, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 9000 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-3666 |